Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Algerian prostate cancer study seeks 2,000 men

NCT ID NCT07484971

Knowledge-focused Sponsor: Société Algérienne de Formation et Recherche en Oncologie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to describe the characteristics of prostate cancer in Algeria, including patient demographics, symptoms, diagnosis methods, and treatments. Researchers will collect data from 2,000 men aged 19 and older with confirmed prostate cancer. The goal is to better understand how prostate cancer is managed in Algeria, but this study does not test any new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with histologically and/or biologically confirmed prostate cancer, followed in the participating centers.

Ages

19 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 19 years and older. * Diagnosis of prostate cancer confirmed histologically and/or biologically. * Patients followed in the participating oncology departments. * Written informed consent obtained. Non Inclusion Criteria: * Histological types other than carcinoma * Secondary tumors * Participation in an interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adenocarcinoma disease metastatic prostate carcinoma neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prostate cancer Prostate cancer (adenocarcinoma) Prostate cancer (diagnosis) Prostate cancer (post prostatectomy) Prostate cancer metastatic Prostate cancer patients treated by radiotherapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    24 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CAC Adrar - Oncology Department

    NOT_YET_RECRUITING

    Adrar, Algeria, 01000, Algeria

    Contact Email: •••••@•••••

  • CAC Adrar - Radiotherapy Department

    NOT_YET_RECRUITING

    Adrar, Algeria, 01000, Algeria

    Contact Email: •••••@•••••

  • CAC Annaba - Oncology Departement

    RECRUITING

    Annaba, Algeria, 23000, Algeria

    Contact Email: •••••@•••••

  • CAC Annaba - Radiotherapy Department

    RECRUITING

    Annaba, Algeria, 23000, Algeria

    Contact Email: •••••@•••••

  • CAC Annaba - Urology Departement

    RECRUITING

    Annaba, Algeria, 23000, Algeria

    Contact Email: •••••@•••••

  • CAC BLIDA - Oncology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • CAC BLIDA - Urology Department

    RECRUITING

    Blida, Algeria, 09000, Algeria

    Contact Email: •••••@•••••

  • CAC Bida - Radiotherapy Department

    RECRUITING

    Blida, Algeria, 09000, Algeria

    Contact Email: •••••@•••••

  • CAC Draa Ben Khedda - Radiotherapy Departement

    RECRUITING

    Tizi Ouzou, Algeria, 15000, Algeria

    Contact Email: •••••@•••••

  • CAC ORAN - Oncology Department

    RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • CAC ORAN - Radiotherapy Department

    RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • CAC Sétif - Oncology Departement

    RECRUITING

    Sétif, Algeria, 19000, Algeria

    Contact Email: •••••@•••••

  • CAC Sétif - Radiotherapy Department

    RECRUITING

    Sétif, Algeria, 19000, Algeria

    Contact Email: •••••@•••••

  • CHU Bab El Oued

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • CHU Béni Messous - Oncology Departement

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • CHU Constantine - Oncology Departement

    RECRUITING

    Constantine, Algeria, 25000, Algeria

    Contact Email: •••••@•••••

  • Centre Pierre et Marie Curie - Oncology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • Centre Pierre et Marie Curie - Radiology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • EH Constantine - Oncology Departement

    RECRUITING

    Constantine, Algeria, 25000, Algeria

    Contact Email: •••••@•••••

  • EHU ORAN - Oncology Department

    NOT_YET_RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • EHU ORAN - Urology Department

    RECRUITING

    Oran, Algeria, 31000, Algeria

    Contact Email: •••••@•••••

  • EPH Mostaghanem - Oncology Department

    RECRUITING

    Mostaganem, Algeria, 27000, Algeria

    Contact Email: •••••@•••••

  • EPH ROUIBA - Oncology Department

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • EPH Sidi Ghilès - Oncology Department

    RECRUITING

    Tipasa, Algeria, 42000, Algeria

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.